Offer - Urjas Oil for just ₹ 1
Gliptagreat M 500 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Is the use of Gliptagreat M 500 Tablet safe for pregnant women?
Gliptagreat M Tablet may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Gliptagreat M Tablet again without your doctor's advice.
Is the use of Gliptagreat M 500 Tablet safe during breastfeeding?
Gliptagreat M Tablet does not show any harmful effects in lactating women.
What is the effect of Gliptagreat M 500 Tablet on the Kidneys?
There can be some harmful effects on your kidneys after taking Gliptagreat M Tablet. If you witness any side effects, discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Gliptagreat M 500 Tablet on the Liver?
There may be an adverse effect on the liver after taking Gliptagreat M Tablet. If you observe any side effects on your body then stop taking this drug. Take this medicine again only if your doctor advises you to do so.
What is the effect of Gliptagreat M 500 Tablet on the Heart?
Information about safety of Gliptagreat M Tablet for heart is not available since scientific research on this is yet to be done.
If you are suffering from any of the following diseases, you should not take Gliptagreat M 500 Tablet unless your doctor advises you to do so -
Is this Gliptagreat M 500 Tablet habit forming or addictive?
No, you will not get addicted to Gliptagreat M 500 Tablet.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Gliptagreat M 500 Tablet can make you feel drowsy.
Is it safe?
Gliptagreat M 500 Tablet should be used only after doctor's advice.
Is it able to treat mental disorders?
Gliptagreat M 500 Tablet is unable to treat or cure mental disorders.
Interaction between Food and Gliptagreat M 500 Tablet
There is no information on the effects of taking Gliptagreat M 500 Tablet with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Gliptagreat M 500 Tablet
It is difficult to say anything about the effect of Gliptagreat M 500 Tablet and alcohol. No research has been done on this yet.
Gliptagreat M Tablet is not a known cause of alopecia (hair loss). However, the conditions treated by Gliptagreat M Tablet type 2 diabetes and PCOS, often list hair loss as a possible symptom.
Gliptagreat M Tablet contain metformin, is an oral antidiabetic drug which belongs to the class of biguanide. It is the first-line medication for the treatment of type 2 diabetes, particularly in people who are overweight. It is also used in the treatment of polycystic ovary syndrome. Moreover, it also reduces the risk of cardiovascular complications of diabetes.
Gliptagreat M Tablet can be taken forever, diabetes is a progressive disease it's possible that more medication and/or insulin may eventually need to be added to the regime.
Gliptagreat M Tablet should be taken with food to reduce stomach and bowel side effects, which may experience the first few weeks of treatment. Also, exercise regularly and test for sugar in your blood or urine as directed.
Yes, Gliptagreat M Tablet is safe to use, many people have side effects at first, they usually diminish and then go away completely in a few weeks. A few people find they cannot tolerate metformin, there are other drugs but metformin is usually the first choice. It is very safe
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275